Submitted by Anonymous (not verified) on 27 November 2023 - 9:34
Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Acromegaly, Date of authorisation: 12/11/2002, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Acromegaly, Date of authorisation: 12/11/2002, Revision: 28, Status: Authorised